Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report)’s stock price traded down 1.7% on Thursday . The stock traded as low as $65.00 and last traded at $65.00. 200 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 344 shares. The stock had previously closed at $66.10.
Bioqual Stock Performance
The business’s 50-day simple moving average is $67.09 and its 200-day simple moving average is $69.15. The company has a market capitalization of $58.11 million, a PE ratio of -52.85 and a beta of -0.34.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The company reported ($0.76) earnings per share for the quarter. The business had revenue of $11.77 million during the quarter. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.
About Bioqual
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
See Also
- Five stocks we like better than Bioqual
- Pros And Cons Of Monthly Dividend Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Investing In Automotive Stocks
- Nebius Group: The Rising Star in AI Infrastructure
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
